Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes (Q34646866)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes |
scientific article |
Statements
1 reference
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes (English)
1 reference
Liliana Grinfeld
1 reference
Gerasimos Filippatos
1 reference
G Michael Felker
1 reference
John R Teerlink
1 reference
Adriaan A Voors
1 reference
Barry H Greenberg
1 reference
Sam L Teichman
1 reference
Elaine Unemori
1 reference
Kirkwood F Adams
1 reference
Maria I Dorobantu
1 reference
Guillaume Jondeau
1 reference
Alon Marmor
1 reference
Angelo Trapani
1 reference
Rajnish Saini
1 reference
Christoph Schumacher
1 reference
RELAX-AHF Investigators
1 reference
Josep Masip
1 reference
Karl Werdan
1 reference
Margaret F Prescott
1 reference
Christopher Edwards
1 reference
Christopher A Bush
1 reference
Thomas Severin
1 reference
1 January 2013
1 reference
1 reference
61
1 reference
2
1 reference
196-206
1 reference
Identifiers
1 reference
1 reference